Company Tianjin Chase Sun Pharmaceutical Co.,Ltd

Equities

300026

CNE100000GF1

Pharmaceuticals

End-of-day quote Shenzhen S.E. 18:00:00 2024-07-18 EDT 5-day change 1st Jan Change
3.19 CNY -0.62% Intraday chart for Tianjin Chase Sun Pharmaceutical Co.,Ltd +0.95% -24.76%

Business Summary

Tianjin Chase Sun Pharmaceutical Co.,Ltd is a China-based company principally engaged in the research, development, manufacture and distribution of pharmaceuticals. The Company's main products include Chinese traditional formula granules, Xuebijing injection, fasudil hydrochloride injection, low molecular weight heparin calcium injection, bulk drugs and excipient, among others. The Company also provides medical apparatus and instrument. The Company distributes its products in domestic market and to overseas markets.

Sales per Business

CNY in Million2022Weight2023Weight Delta
Traditional Chinese Medicine Formula Granules and Decoction Pieces
47.9 %
3,360 50.5 % 2,923 47.9 % -12.99%
Blood-essential Injection
13.9 %
817 12.3 % 851 13.9 % +4.23%
Smart Pharmaceutical Supply Chain
11.7 %
588 8.8 % 715 11.7 % +21.66%
Medical Device
6.3 %
674 10.1 % 383 6.3 % -43.12%
Excipients
5.6 %
361 5.4 % 344 5.6 % -4.80%
Low Molecular Weight Heparin Calcium Injection
4.7 %
305 4.6 % 287 4.7 % -5.82%
Moxifloxacin Hydrochloride Sodium Chloride Injection
3.1 %
165 2.5 % 189 3.1 % +14.49%
Other Products
3.1 %
233 3.5 % 189 3.1 % -18.85%
API
2.6 %
147 2.2 % 156 2.6 % +6.07%
Enoxaparin Sodium Injection
1.2 %
- - 71 1.2 % -

Sales per region

CNY in Million2022Weight2023Weight Delta
China
93.5 %
5,923 89.1 % 5,167 93.5 % -12.77%
Overseas
6.5 %
727 10.9 % 361 6.5 % -50.29%

Managers

Managers TitleAgeSince
Chief Executive Officer 60 -
Director of Finance/CFO 49 -
Director/Board Member 55 -
Director/Board Member 43 13-04-15
Human Resources Officer 47 15-06-24
Corporate Officer/Principal 54 19-04-25

Members of the board

Members of the board TitleAgeSince
Founder 59 96-09-22
Director/Board Member 61 20-01-15
Director/Board Member 52 23-07-11
Chief Executive Officer 60 -
Director of Finance/CFO 49 -
Director/Board Member 69 07-05-07
Director/Board Member 43 13-04-15
Director/Board Member 55 20-01-15
Director/Board Member 73 17-12-27
Director/Board Member 61 20-01-15

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,004,154,837 1,777,676,217 ( 59.17 %) 0 59.17 %

Shareholders

NameEquities%Valuation
Chengdu State Owned-Assets Sup. & Admin. Commission
23.69 %
634,997,417 23.69 % 267 M ¥
150,205,693 5.603 % 63 M ¥
60,519,486 2.257 % 25 M ¥
Zhuo Li
2.015 %
54,011,767 2.015 % 23 M ¥
39,906,715 1.489 % 17 M ¥
17,097,116 0.6377 % 7 M ¥
China Southern Asset Management Co., Ltd.
0.6203 %
16,629,933 0.6203 % 7 M ¥
E Fund Management Co., Ltd.
0.5088 %
13,640,400 0.5088 % 6 M ¥
Galaxy Asset Management Co., Ltd.
0.2782 %
7,459,827 0.2782 % 3 M ¥
Fullgoal Fund Management Co., Ltd.
0.2493 %
6,684,800 0.2493 % 3 M ¥
NameEquities%Valuation
246,958,242 76.42 % 104 M ¥

Company contact information

Tianjin Chase Sun Pharmaceutical Co., Ltd.

B01 Building Entrepreneurship Headquarters Base

301700, Tianjin

+86 22 5962 3160

http://www.chasesun.cn
address Tianjin Chase Sun Pharmaceutical Co.,Ltd(300026)
  1. Stock Market
  2. Equities
  3. 300026 Stock
  4. Company Tianjin Chase Sun Pharmaceutical Co.,Ltd